financetom
Business
financetom
/
Business
/
Former Dallas Fed President Robert Kaplan Rejoins Goldman Sachs as Vice Chairman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Former Dallas Fed President Robert Kaplan Rejoins Goldman Sachs as Vice Chairman
May 7, 2024 8:30 AM

10:39 AM EDT, 05/07/2024 (MT Newswires) -- Former President of the Federal Reserve Bank of Dallas Robert Kaplan has rejoined Goldman Sachs ( GS ) as vice chairman and member of the Management Committee, the company said Tuesday.

Kaplan worked at Goldman Sachs ( GS ) from 1983-2006. Most recently, he served as president and chief executive of the Dallas Fed from 2015-2021, the company said.

Price: 446.60, Change: +2.93, Percent Change: +0.66

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ball, O-I Glass, Sylvamo Show Momentum, Catalysts, Value, BofA Says
Ball, O-I Glass, Sylvamo Show Momentum, Catalysts, Value, BofA Says
Nov 17, 2025
12:05 PM EST, 11/17/2025 (MT Newswires) -- Ball (BALL), O-I Glass ( OI ) , and Sylvamo ( SLVM ) have momentum and catalysts that make them attractive, BofA Securities said Monday in a research note updating its packaging, paper, and forest products coverage for year-end. Analysts said Ball should grow in line with or above the industry over the...
Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans
Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans
Nov 17, 2025
Zymeworks Inc. ( ZYME ) stock is surging on Monday, with a session volume of 2.17 million, compared to an average volume of 728.75K, according to Benzinga Pro. Zymework, along with its partners, Jazz Pharmaceuticals Inc. and BeOne Medicines Inc. , announced topline results from the Phase 3 HERIZON-GEA-01 trial. The study evaluated Ziihera (zanidatamab-hrii) in combination with chemotherapy, with or...
Rocket Lab (RKLB) Stock Continues To Fall: What's Happening?
Rocket Lab (RKLB) Stock Continues To Fall: What's Happening?
Nov 17, 2025
Shares of Rocket Lab Corp ( RKLB ) are trading lower Monday, potentially on continued downward momentum. The company last week reported third-quarter earnings and multiple operational updates. The stock is also continuing a recent sell-off that has erased 22% of gains over the last week and 35% over the past month. Macro headwinds have been to blame. Hawkish comments...
Alphabet Shares Rise After Berkshire Hathaway Discloses $4.33 Billion Stake
Alphabet Shares Rise After Berkshire Hathaway Discloses $4.33 Billion Stake
Nov 17, 2025
12:03 PM EST, 11/17/2025 (MT Newswires) -- Alphabet (GOOG, GOOGL) shares rose nearly 5% in recent Monday trading after Berkshire Hathaway ( BRK/A ) (BRK.A, BRK.B) disclosed on Friday a $4.33 billion stake in Google's ( GOOG ) parent company as of Sept. 30. Berkshire Hathaway ( BRK/A ) purchased over 17.8 million shares of Alphabet class A shares, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved